Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Declines By 18.4%

BiomX Inc. (NYSEAMERICAN:PHGE) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 55,500 shares, a drop of 18.4% from the November 15th total of 68,000 shares. Based on an average daily volume of 86,400 shares, the short-interest ratio is presently 0.6 days. Currently, 0.5% of the shares of the company are sold short.

BiomX Price Performance

BiomX stock remained flat at $0.63 during mid-day trading on Friday. 32,380 shares of the company were exchanged, compared to its average volume of 108,822. The stock has a market cap of $11.53 million, a price-to-earnings ratio of -0.20 and a beta of 1.31. BiomX has a fifty-two week low of $0.48 and a fifty-two week high of $8.55.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).